Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-02-08
2010-11-16
Gusow, Anne M. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S391100, C530S391300, C530S391500, C424S130100, C424S133100, C424S134100, C424S178100
Reexamination Certificate
active
07834154
ABSTRACT:
The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods.
REFERENCES:
patent: 6069007 (2000-05-01), Rossi et al.
patent: 6225118 (2001-05-01), Grant et al.
patent: 7112317 (2006-09-01), Thorpe et al.
patent: 7163797 (2007-01-01), Ruben et al.
patent: 7459931 (2008-12-01), Tang et al.
patent: 2003/0027993 (2003-02-01), Eaton et al.
patent: 2003/0072736 (2003-04-01), Baker et al.
patent: 2003/0236210 (2003-12-01), Geng
patent: 2004/0071711 (2004-04-01), Bicknell et al.
patent: 2006/0099143 (2006-05-01), Bicknell et al.
patent: 2006/0160729 (2006-07-01), Li et al.
patent: 2006/0205034 (2006-09-01), Fraser et al.
patent: 2007/0025913 (2007-02-01), Bicknell et al.
patent: 0682113 (1995-11-01), None
patent: 1074617 (2001-02-01), None
patent: 99/06423 (1999-02-01), None
patent: 99/11293 (1999-03-01), None
patent: 99/46281 (1999-09-01), None
patent: 99/53051 (1999-10-01), None
patent: 00/53756 (2000-09-01), None
patent: 01/23523 (2001-04-01), None
patent: 02/22660 (2002-03-01), None
patent: 02/36771 (2002-05-01), None
patent: 2004/046191 (2004-06-01), None
patent: 2005/014051 (2005-02-01), None
patent: 2005/044853 (2005-05-01), None
patent: 2006/042173 (2006-04-01), None
Skolnick and Fetrow. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotechnology, 2000. vol. 18, pp. 34-39.
Burgess, Shaheen, Ravera, Jaye, Donohue, and Winkles. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor binding activities by site directed mutagenesis of a single lysine residue. Journal of Cell Biology, 1990. vol. 111, pp. 2129-2138.
Lazar, Watanabe, Dalton, and Sporn. Transforming growth factor a: mutation of aspartic acid 47 and leucine 48 results in different biological activities. Molecular and Cellular Biology, 1988. vol. 8, pp. 1247-1252.
Holm, Jafari, and Sundstrom. Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1. Molecular Immunology, 2007. vol. 44, pp. 1075-1084.
Chen, Wiesmann, Fuh, Li, Christinger, Mc Kay, De Vos, and Lowman. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity matured Fab in complex with antigen. Journal of Molecular Biology, 1999. vol. 293, pp. 865-881.
Rudikoff, Giusti, Cook, and Scharff. Single amino acid substitution altering antigen-binding specificity. Proceedings of the National Academy of Sciences, 1982. vol. 79, pp. 1979-1983.
Mac Callum, Martin, and Thornton. Antibody-antigen interactions: contact analysis and binding site topography. Journal of Molecular Biology, 1996. vol. 262, pp. 732-745.
De Pascalis, Iwahasi, Tamura, Padlan, Gonzales, Santos, Giuliano, Schuck, Schlom, and Kashmiri. Grafting of abbreviated complementarity determining regions containing specificity determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody. Journal of Immunology, 2002. vol. 169, pp. 3076-3084.
Casset, Roux, Mouchet, Bes, Chardes, Granier, Mani, Pugniere, Laune, Pau, Kaczorek, Lahana, and Rees. Biochemical and Biophysical Research Communications, 2003. vol. 307, pp. 198-205.
Vajdos, Adams, Breece, Presta, De Vos, and Sidhu. Comprehensive functional maps of the antigen binding site of an anti-ErbB2 antibody obtained by shotgun scanning mutagenesis. Journal of Molecular Biology, 2002. vol. 320, pp. 415-428.
Wu, Nie, Huse, and Watkins. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues. Journal of Molecular Biology, 1999. vol. 294, pp. 151-162.
Fujiwara, M. et al., “Potential role of the Slit/Robo signal pathway in angiogensis”Vascular Medicine11(2):115-121 (May 1, 2006).
Hoogenboom, “Selecting and screening recombinant antibody libraries”Nature Biotechnology23(9):1105-1116 (Sep. 1, 2005).
Aaronson et al., “Toward the Development of a Gene Index to the Human Genome: an Assessment of the Nature of High-Throughput EST Sequence Data”Genome Research6:829-845 (1996).
Abbas et al., “Chapter Three Antibodies and Antigens”Cellular and Molecular Immunology, 2nd edition pp. 41-43 (1994).
Adams et al., “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence”Nature377(SUPPL):3-174 (Sep. 28, 1995).
Adams, R.H., et al., “Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis”Genes and Development13:295-306 (1999).
Aiello et al., “Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF- receptor chimeric proteins”Proc. Natl. Acad. Sci. USA92:10457-10461 (Nov. 1995).
Amalfitano et al., “Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy”Current Gene Therapy2(2):111-133 (2002).
AngioKit Protocol, Catalogue No. ZHA-1000, by TCS CellWorks Ltd, Buckingham MK18 2LR, UK (pp. 1-16), 2008.
Asano et al., “Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121”Cancer Research55:5296-5301 (Nov. 15, 1995).
Banerji et al., “LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan”Journal of Cell Biology144(4):789-801 (Feb 1999).
Bashaw et al., “Chimeric Axon Guidance Receptors: The Cytoplasmic Domains of Slit and Netrin Receptors Specify Attraction Versus Repulsion”Cell97:917-926 (Jun. 25, 1999).
Bashaw et al., “Repulsive Axon Guidance: Abelson and Enabled Play Opposing Roles Downstream of the Roundabout Receptor”Cell101:703-715 (Jun. 23, 2000).
Bates et al., “Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells”European Journal of Immunology27:2471-2477 (1997).
BD BioCoat™ Angiogenesis System—Endothelial Cell Migration; available as Catalog No. 354143 from BD Biosciences, Bedford, MA (2002) (6 pages).
Bechard et al., “Characterization of the Secreted Form of Endothelial-Cell Specific Molecule 1 by Specific Monoclonal Antibodies”J Vasc Res. 37:417-425 (2000).
Bedell et al., “roundabout4 is essential for angiogenesis in vivo”Proc. Natl. Acad. Sci. USA102(18):6373-8 (May 3, 2005).
Bernstein et al., “Characterization of a Human Fovea cDNA Library and Regional Differential Gene Expression in the Human Retina”Genomics32:301-308 (1996).
Bortoluzzi et al., “The Human Adult Skeletal Muscle Transcriptional Profile Reconstructed by a Novel Computational Approach”Genome Research10:344-349 (2000).
Boyle et al., “DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity”Proc. Nat'l Acad. Sci. USA94:14626-14631 (Dec. 1997).
Brose et al., “Slit Proteins Bind Robo Receptors and Have an Evolutionarily Conserved Role in Repulsive Axon Guidance”Cell96:795-806 (Mar. 19, 1999).
Casset, F. et al., “A peptide mimetic of an anti-CD4 monoclonal antibody by rational design”Biochem.&Biophys. Res. Comm. 307:198-205 (2003).
Chatterjee et al., “Idiotypic antibody immunotherapy of cancer”Cancer Immunol Immunother. 38:75-82 (1994).
Chen et al., “Characterization of Gene Expression in Resting and Activated Mast Cells”Journal of Experimental Medicine188(9):1657-1668 (Nov. 2, 1998).
Clark et al., “Localization of VEGF and expression of its receptors fit and KDR in human placenta throughout pregnancy”Human Reproduction11(5):1090-1098 (1996).
Cole et al., “The Genetics of Cancer—a 3D
Carano Richard
Koch Alexander W.
Peale, Jr. Franklin V.
Stawicki Scott
Watts Ryan J.
Fang Carol
Genentech Inc.
Gusow Anne M.
LandOfFree
Anti-ROBO4 antibodies and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-ROBO4 antibodies and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-ROBO4 antibodies and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4241907